FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1824353359> ?p ?o ?g. }

• W1824353359 endingPage "2344" @default.
• W1824353359 startingPage "2337" @default.
• W1824353359 abstract "We have explored different domains within the hepatitis C virus (HCV) 5' noncoding region as potential targets for inhibition of HCV translation by antisense oligodeoxynucleotides (ODNs). Inhibition assays were performed with two different cell-free systems, rabbit reticulocyte lysate and wheat germ extract, and three types of chemical structures for the ODNs were evaluated: natural phosphodiesters (beta-PO), alpha-anomer phosphodiesters (alpha-PO), and phosphorothioates (PS). A total of six original ODNs, displaying sequence-specific inhibition ranging from 62 to 96%, that mapped in the pyrimidine-rich tract (nucleotides [nt] 104 to 127) and in the initiator AUG codon (nt 338 to 357) were identified. Two ODNs, which were targeted at the initiatory AUG (nt 341 to 367 and 351 to 377) and which had been previously described as active against genotype 1b and 2a sequences, were shown to exhibit inhibition of expression (> 95%) of a type 1a sequence. Control experiments with the irrelevant chloramphenicol acetyltransferase sequence as a marker and randomized ODNs demonstrated that levels of inhibition associated with the use of PS compounds (of as much as 94%) were mainly due to nonspecific effects. Both alpha- and beta-PO ODNs were found equally active, and no difference could be seen in the activity of beta-PO when it was tested in either rabbit reticulocyte lysate or wheat germ extract, suggesting that RNase H-independent mechanisms may be involved in the inhibitions observed. However, specific RNA cleavage products generated from beta-PO inhibition experiments could be identified, indicating that, with these compounds, control of translation also involves RNase H-dependent mechanisms. This study further delimits the existence of favorable target sequences for the action of ODNs within the HCV 5' noncoding region and indicates the possibility of using nuclease-resistant alpha-PO compounds in cellular studies." @default.
• W1824353359 created "2016-06-24" @default.
• W1824353359 creator A5026293971 @default.
• W1824353359 creator A5057753972 @default.
• W1824353359 creator A5058830854 @default.
• W1824353359 creator A5071109351 @default.
• W1824353359 creator A5090061858 @default.
• W1824353359 creator A5091746611 @default.
• W1824353359 date "1996-10-01" @default.
• W1824353359 modified "2023-10-16" @default.
• W1824353359 title "In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides" @default.
• W1824353359 cites W1486067148 @default.
• W1824353359 cites W1488795182 @default.
• W1824353359 cites W1573240065 @default.
• W1824353359 cites W1574175588 @default.
• W1824353359 cites W1647141819 @default.
• W1824353359 cites W1678781278 @default.
• W1824353359 cites W1796179288 @default.
• W1824353359 cites W1836032532 @default.
• W1824353359 cites W1914838920 @default.
• W1824353359 cites W1938755197 @default.
• W1824353359 cites W1970403529 @default.
• W1824353359 cites W1970650788 @default.
• W1824353359 cites W1974879228 @default.
• W1824353359 cites W1976275995 @default.
• W1824353359 cites W1977469144 @default.
• W1824353359 cites W1981481692 @default.
• W1824353359 cites W1985310833 @default.
• W1824353359 cites W1990333416 @default.
• W1824353359 cites W1998919839 @default.
• W1824353359 cites W2001233143 @default.
• W1824353359 cites W2003598383 @default.
• W1824353359 cites W2006309458 @default.
• W1824353359 cites W2010251227 @default.
• W1824353359 cites W2015539080 @default.
• W1824353359 cites W2016216355 @default.
• W1824353359 cites W2022495840 @default.
• W1824353359 cites W2034477909 @default.
• W1824353359 cites W2039534591 @default.
• W1824353359 cites W2042038647 @default.
• W1824353359 cites W2048731469 @default.
• W1824353359 cites W2050014764 @default.
• W1824353359 cites W2067060571 @default.
• W1824353359 cites W2078571233 @default.
• W1824353359 cites W2084901266 @default.
• W1824353359 cites W2087021327 @default.
• W1824353359 cites W2094576653 @default.
• W1824353359 cites W2102989311 @default.
• W1824353359 cites W2124528668 @default.
• W1824353359 cites W2129231987 @default.
• W1824353359 cites W2134812217 @default.
• W1824353359 cites W2143450436 @default.
• W1824353359 cites W2148510296 @default.
• W1824353359 cites W2152793674 @default.
• W1824353359 cites W2160425277 @default.
• W1824353359 cites W2237083266 @default.
• W1824353359 cites W2334978547 @default.
• W1824353359 cites W260828612 @default.
• W1824353359 cites W39399998 @default.
• W1824353359 doi "https://doi.org/10.1128/aac.40.10.2337" @default.
• W1824353359 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/163531" @default.
• W1824353359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8891141" @default.
• W1824353359 hasPublicationYear "1996" @default.
• W1824353359 type Work @default.
• W1824353359 sameAs 1824353359 @default.
• W1824353359 citedByCount "36" @default.
• W1824353359 countsByYear W18243533592014 @default.
• W1824353359 crossrefType "journal-article" @default.
• W1824353359 hasAuthorship W1824353359A5026293971 @default.
• W1824353359 hasAuthorship W1824353359A5057753972 @default.
• W1824353359 hasAuthorship W1824353359A5058830854 @default.
• W1824353359 hasAuthorship W1824353359A5071109351 @default.
• W1824353359 hasAuthorship W1824353359A5090061858 @default.
• W1824353359 hasAuthorship W1824353359A5091746611 @default.
• W1824353359 hasBestOaLocation W18243533591 @default.
• W1824353359 hasConcept C104317684 @default.
• W1824353359 hasConcept C10879258 @default.
• W1824353359 hasConcept C153911025 @default.
• W1824353359 hasConcept C185592680 @default.
• W1824353359 hasConcept C2778403015 @default.
• W1824353359 hasConcept C2778976237 @default.
• W1824353359 hasConcept C512185932 @default.
• W1824353359 hasConcept C55493867 @default.
• W1824353359 hasConcept C67705224 @default.
• W1824353359 hasConcept C69766542 @default.
• W1824353359 hasConcept C86803240 @default.
• W1824353359 hasConceptScore W1824353359C104317684 @default.
• W1824353359 hasConceptScore W1824353359C10879258 @default.
• W1824353359 hasConceptScore W1824353359C153911025 @default.
• W1824353359 hasConceptScore W1824353359C185592680 @default.
• W1824353359 hasConceptScore W1824353359C2778403015 @default.
• W1824353359 hasConceptScore W1824353359C2778976237 @default.
• W1824353359 hasConceptScore W1824353359C512185932 @default.
• W1824353359 hasConceptScore W1824353359C55493867 @default.
• W1824353359 hasConceptScore W1824353359C67705224 @default.
• W1824353359 hasConceptScore W1824353359C69766542 @default.
• W1824353359 hasConceptScore W1824353359C86803240 @default.
• W1824353359 hasIssue "10" @default.

• next